Johnson & Johnson - 46 Year Dividend History | JNJ

Historical dividend payout and yield for Johnson & Johnson (JNJ) since 1972. The current TTM dividend payout for Johnson & Johnson (JNJ) as of July 17, 2018 is $3.60. The current dividend yield for Johnson & Johnson (JNJ) as of July 17, 2018 is 2.89%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.237B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $222.518B 13.69
Novartis AG (NVS) Switzerland $182.129B 15.78
Merck (MRK) United States $168.755B 15.08
AbbVie (ABBV) United States $152.737B 15.57
Novo Nordisk (NVO) Denmark $121.004B 20.05
Sanofi (SNY) France $104.713B 13.25
GlaxoSmithKline (GSK) United Kingdom $102.153B 13.97
Eli Lilly (LLY) United States $96.679B 19.20
AstraZeneca (AZN) United Kingdom $92.856B 9.72
Bristol-Myers Squibb (BMY) United States $92.237B 18.15